GSK Plc
NYSE: GSK
$41.78
-$0.65 (-1.5%)
Real Time Data Delayed 15 Min.
GSK Articles
The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty and Yum China.
Published:
Last Updated:
If Warren Buffett is considered the greatest investor of the modern era, and if he has held the title of the world's richest man, then maybe he knows a thing or two.
Published:
Last Updated:
With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag.
Published:
Last Updated:
Wednesday’s top analyst upgrades, downgrades and initiations included AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor and Wynn Resorts,
Published:
Last Updated:
For the past couple of months, Wall Street strategists and portfolio managers has been championing European stocks as better buys now than U.S. stocks.
Published:
Last Updated:
Berkshire Hathaway has released its public equity holdings as of December 31, 2016, and the number of changes in the equity portfolio were nothing short of massive.
Published:
Last Updated:
With the markets warming up to the reality of a Donald Trump presidency and administration, some people have become nervous about dividend-paying stocks as they see higher interest rates and...
Published:
Last Updated:
While these out-of-favor stocks may still remain volatile, buying these top companies at deep discounts may end up being one of the best trades for the rest of 2016 and 2017.
Published:
Last Updated:
Some of the top European companies are offering outstanding dividends to investors, many of which are higher than their U.S. counterparts.
Published:
Last Updated:
Alkermes' positive Phase 3 results for its novel antidepressant is serving as a rising tide — a storm surge even — for many biotech companies in the depression space.
Published:
Last Updated:
Rates are still near the lowest levels in history, but by the way dividend stocks are being sold, you would think the late 1970s and early 1980s were right around the corner.
Published:
Last Updated:
With the 10-year Treasury yielding much less than 2% and the prospects for big capital gains going forward far lower than over the past 10 years, switching to top dividend stocks now looks like a...
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday morning include Activision Blizzard, Electronic Arts, Transocean, Twitter, Wal-Mart and Yum Brands.
Published:
Last Updated:
It’s getting harder and harder for investors seeking income. Most investors are looking for yields that are at least 4% and have some degree of safety as well.
Published:
Last Updated:
A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in the top position.
Published:
Last Updated: